Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Baxter
US Department of Justice
Deloitte
Cipla
Julphar
McKinsey
Federal Trade Commission
Cantor Fitzgerald
Cerilliant

Generated: February 18, 2018

DrugPatentWatch Database Preview

SINOGRAFIN Drug Profile

« Back to Dashboard

When do Sinografin patents expire, and what generic alternatives are available?

Sinografin is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in SINOGRAFIN is diatrizoate meglumine; iodipamide meglumine. There are nine drug master file entries for this compound. Additional details are available on the diatrizoate meglumine; iodipamide meglumine profile page.
Summary for SINOGRAFIN
Drug patent expirations by year for SINOGRAFIN

US Patents and Regulatory Information for SINOGRAFIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco SINOGRAFIN diatrizoate meglumine; iodipamide meglumine SOLUTION;INTRAUTERINE 011324-002 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Chubb
Citi
AstraZeneca
Merck
Covington
Queensland Health
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot